- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-278/25 R: Order of the President of the General Court of 2 July 2025 – Duchenne Research & Advocacy v Commission (Interim relief – Medicinal products for human use – Refusal to renew the conditional marketing authorisation for Translarna – ataluren – Application for suspension of operation of a measure – Application for interim measures – Failure to comply with procedural requirements – Inadmissibility)
ECLI:EU:UNKNOWN:62025TB0278
62025TB0278
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2025/4612
(Case T-278/25 R)
(Interim relief - Medicinal products for human use - Refusal to renew the conditional marketing authorisation for Translarna - ataluren - Application for suspension of operation of a measure - Application for interim measures - Failure to comply with procedural requirements - Inadmissibility)
(C/2025/4612)
Language of the case: Italian
Parties
Applicant: Associazione Duchenne Research & Advocacy APS (Parma, Italy) (represented by: V. Salvatore and G. Ragucci, lawyers)
Defendant: European Commission (represented by: E. Mathieu and A. Spina, acting as Agents)
Re:
By its action under Articles 278 and 279 TFEU, the applicant seeks, inter alia, suspension of the operation of Commission Implementing Decision C(2025) 2025 final of 28 March 2025 refusing the renewal of the conditional marketing authorisation for the medicinal product for human use Translarna – ataluren, granted by Decision C(2014)5619 final.
Operative part of the order
The application for interim measures is dismissed.
The costs are reserved.
—
ELI: http://data.europa.eu/eli/C/2025/4612/oj
ISSN 1977-091X (electronic edition)
—